| Breast Cancer Metastases |
Sanofi-Aventis |
NCT00081796 |
Clinical Trial URL |
Drug: RPR109881 IV |
III |
| Desmosterolosis |
National Institute of Child Health and Human Development |
NCT00046202 |
Clinical Trial URL |
- |
NA |
| Esophageal Cancer |
James P. Wilmot Cancer Center |
NCT00258297 |
Clinical Trial URL |
Drug: gefitinib |
II |
| Gastric Cancer |
Institut Bergonié Novartis Sanofi-Synthelabo Aventis Pharmaceuticals |
NCT00210184 |
Clinical Trial URL |
Drug: Irinotecan associated to fluorouracil and elvorin |
II |
| Glioblastoma |
Assistance Publique - Hôpitaux de Paris |
NCT00190424 |
Clinical Trial URL |
Drug: CpG-ODN |
II |
| Rhabdomyosarcomas, Soft parts tissue, Ewing Tumor, Osteosarcomas, Neuroblastomas, Medulloblastoma |
Institut Gustave Roussy |
NCT00180947 |
Clinical Trial URL |
"Drug: Vinorelbine, cyclofosfamide" |
II |
| Basal Cell Carcinoma |
Peplin |
NCT00108121 |
Clinical Trial URL |
Drug: PEP005 |
II |
| Pancreatic Cancer, Pancreatic Neoplasms, Metastatic Pancreatic Cancer |
Pfizer |
NCT00219557 |
Clinical Trial URL |
Drug: VEGFR and PDGFR inhibitor |
II |
| Advanced Prostate Cancer, Prostate Cancer |
Massachusetts General Hospital, Dana Farber Harvard Cancer Center, PharmaMar, Dana-Farber Cancer Institute |
NCT00147212 |
Clinical Trial URL |
Drug: ET 743 (Yondelis) |
II |
| Small Cell Lung Cancer |
Amgen |
NCT00119613 |
Clinical Trial URL |
Drug: darbepoetin alfa |
III |
| Basal Cell Carcinoma |
Genentech & Curis |
- |
Clinical Trial URL |
Drug: CUR-61414/G-024856 |
I |
| Stroke |
Wyeth & Curis |
- |
- |
Hh agonist |
Pre-Clinical |
| Alopecia |
Procter & Gamble and Curis |
- |
Clinical Trial URL |
Hh agonist |
Pre-Clinical |
| Acute and chronic ischemic heart disease |
Curis |
- |
Clinical Trial URL |
Plasmid |
Pre-Clinical |
| Cancer |
Genentech & Curis |
- |
- |
Hh antagonist & antibody |
Pre-Clinical |
